Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company, 13824 [2023-04512]
Download as PDF
13824
Federal Register / Vol. 88, No. 43 / Monday, March 6, 2023 / Notices
Dated: February 27, 2023.
Kimberly D. Bose,
Secretary.
[FR Doc. 2023–04452 Filed 3–3–23; 8:45 am]
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
BILLING CODE 6717–01–P
[FR Doc. 2023–04512 Filed 3–3–23; 8:45 am]
BILLING CODE P
FEDERAL RESERVE SYSTEM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSK11XQN23PROD with NOTICES1
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
Centers for Disease Control and
Prevention
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than March 21, 2023.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Lisa Elsenbast, Minneapolis,
Minnesota, individually and as cotrustee with Annette Sarazine-Jensen,
Omaha, Nebraska, Monica Anderegg,
Edina, Minnesota, and Julia T. Sarazine,
Chicago, Illinois, of the Charles L.
Sarazine 2022 Trust Agreement,
Minneapolis, Minnesota; and Maryanna
Sarazine, Algona, Iowa; to become
members of the Spies-Sarazine Family
Control Group, a group acting in concert
to retain voting shares of Emmetsburg
Bank Shares, Inc., and thereby
indirectly retain voting shares of Iowa
Trust & Savings Bank, both of
Emmetsburg, Iowa.
VerDate Sep<11>2014
19:26 Mar 03, 2023
Jkt 259001
[30Day–23–22IV]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘The Muscular
Dystrophy Surveillance, Tracking, and
Research Network (MD STARnet) Living
with Muscular Dystrophy
Questionnaire’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on
September 23, 2022 to obtain comments
from the public and affected agencies.
CDC did not receive comments related
to the previous notice. This notice
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
The Muscular Dystrophy
Surveillance, Tracking, and Research
Network (MD STARnet) Living with
Muscular Dystrophy Questionnaire—
New—National Center on Birth Defects
and Developmental Disabilities
(NCBDDD), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Since its establishment in 2002, the
MD STARnet has been a populationbased surveillance system that aims to
identify and collect clinical data on
individuals with muscular dystrophy
(MD) in select surveillance areas. MD
STARnet identifies and collects data on
individuals with MD at sources
including healthcare facilities where
patients with MD receive care and
administrative datasets such as vital
records and hospital discharge data.
Although MDs are rare genetic diseases
with an estimated prevalence of 16.1/
100,000, they have a high impact on
affected individuals, their families, and
society. MDs can be classified into nine
major groups: Duchenne MD (DMD),
Becker MD (BMD), myotonic dystrophy
(DM), facioscapulohumeral muscular
dystrophy (FSHD), limb-girdle MD
(LGMD), Congenital MD (CMD), EmeryDreifuss MD (EDMD), Oculopharyngeal
MD (OPMD), and distal MD. A recent
MD STARnet study has estimated the
combined prevalence for DMD and BMD
to be 1.92–2.48/10,000 males age 5–9
years old. MD STARnet aims to improve
understanding of MDs and ultimately
the quality of life of individuals and
their families living with MD.
Individuals with MD frequently report
pain and fatigue, but studies have
primarily been conducted in single
clinics and limited to the three most
common MDs (DMD, DM, and FSHD).
E:\FR\FM\06MRN1.SGM
06MRN1
Agencies
[Federal Register Volume 88, Number 43 (Monday, March 6, 2023)]
[Notices]
[Page 13824]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04512]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices; Acquisitions of Shares of a Bank
or Bank Holding Company
The notificants listed below have applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and Sec. 225.41 of the Board's
Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank
holding company. The factors that are considered in acting on the
applications are set forth in paragraph 7 of the Act (12 U.S.C.
1817(j)(7)).
The public portions of the applications listed below, as well as
other related filings required by the Board, if any, are available for
immediate inspection at the Federal Reserve Bank(s) indicated below and
at the offices of the Board of Governors. This information may also be
obtained on an expedited basis, upon request, by contacting the
appropriate Federal Reserve Bank and from the Board's Freedom of
Information Office at https://www.federalreserve.gov/foia/request.htm.
Interested persons may express their views in writing on the standards
enumerated in paragraph 7 of the Act.
Comments regarding each of these applications must be received at
the Reserve Bank indicated or the offices of the Board of Governors,
Ann E. Misback, Secretary of the Board, 20th Street and Constitution
Avenue NW, Washington DC 20551-0001, not later than March 21, 2023.
A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant
Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414:
1. Lisa Elsenbast, Minneapolis, Minnesota, individually and as co-
trustee with Annette Sarazine-Jensen, Omaha, Nebraska, Monica Anderegg,
Edina, Minnesota, and Julia T. Sarazine, Chicago, Illinois, of the
Charles L. Sarazine 2022 Trust Agreement, Minneapolis, Minnesota; and
Maryanna Sarazine, Algona, Iowa; to become members of the Spies-
Sarazine Family Control Group, a group acting in concert to retain
voting shares of Emmetsburg Bank Shares, Inc., and thereby indirectly
retain voting shares of Iowa Trust & Savings Bank, both of Emmetsburg,
Iowa.
Board of Governors of the Federal Reserve System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023-04512 Filed 3-3-23; 8:45 am]
BILLING CODE P